Summary & Overview
CPT 43611: Excision of Cancerous Stomach Tumor
Headline: CPT code 43611 covers surgical excision of a cancerous stomach tumor, a key procedure in gastric cancer care.
Lead: CPT code 43611 denotes the surgical removal of a malignant gastric tumor to prevent metastasis or to debulk the tumor ahead of radiation or chemotherapy. This operative intervention is central to multidisciplinary cancer management and impacts surgical services utilization and payer reimbursement patterns nationally.
Why it matters: Surgical excision for gastric malignancy directly affects patient prognosis, care pathways, and resource allocation across inpatient and outpatient surgical settings. As definitive or cytoreductive therapy, the procedure influences subsequent oncologic treatments and hospital surgical volumes.
Key payers covered: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare are the primary payers referenced for national coverage and reimbursement considerations.
What readers will learn: The publication provides clinical context for CPT code 43611, outlines typical sites of service, and summarizes the code’s relevance to surgical oncology workflows. Readers will find benchmarks and policy-relevant observations where data is available, along with practical coding context for billing teams and clinical administrators. Data not available in the input will be identified as such.
Billing Code Overview
CPT code 43611 describes the surgical excision of a cancerous tumor of the stomach performed to prevent metastasis or to reduce tumor bulk in preparation for radiation or chemotherapy. This service is a surgical oncology procedure focused on tumor removal within the stomach.
-
Service type: Surgical excision of gastric tumor
-
Typical site of service: Inpatient or outpatient surgical suite at a hospital or specialized surgical center
Clinical & Coding Specifications
Clinical Context
A 64-year-old patient with biopsy-proven gastric adenocarcinoma presents with a bulky, localized gastric tumor causing symptoms of early satiety and weight loss. Imaging (CT abdomen/pelvis with contrast) demonstrates a primary gastric mass without distant metastasis but with concern for regional lymph node involvement. The multidisciplinary tumor board recommends excisional resection of the gastric tumor to reduce tumor burden prior to neoadjuvant chemotherapy and radiation or to attempt curative resection depending on intraoperative findings. The patient is evaluated preoperatively by surgical oncology, medical oncology, and anesthesia; informed consent is obtained. On the day of service the patient undergoes general endotracheal anesthesia, operative excision of the gastric tumor (partial gastrectomy or tumor excision depending on location and extent), intraoperative frozen section as indicated, hemostasis, and placement of drains as needed. Postoperative inpatient recovery includes pain control, early ambulation, diet advancement per enhanced recovery after surgery (ERAS) protocol, pathology review of the specimen for margin status, and coordination of adjuvant or neoadjuvant therapy with oncology based on final staging.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the procedure requires substantially greater work than normal due to severity, such as extensive tumor resection with complex reconstruction. |